study to evaluate the effect of Arkadi Varti in Kaphaj Yonivyapad

Open label single arm clinical study to evaluate the effect of Arkadi Varti in Kaphaj Yonivyapad

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021970

Enrollment

Registered

2019-11-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs

Interventions

Intervention1: arkadi varti: open label single arm clinical study to evaluate the effect of Arkadi Varti in Kaphaj Yonivyapad Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: married diagnosed with kaphaj yonivyapad willing for treatment

Exclusion criteria

Exclusion criteria: pregnancy intermittent pv bleeding drug allergy neoplastic disease systemic disease

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of arkadi varti in kaphaj yonivyapadTimepoint: For maximum 7 days or till relief whichever is earlier	—

Secondary

Measure	Time frame
Study of kaphaj yonivyapad SOP of arkadi varti Adverse effect of arkadi varti role of arkadi varti in kaphaj yonivyapadTimepoint: 14 months	—

Countries

India

Contacts

Public ContactTANAYA SHARAD BANODKAR

sane guruji arogya kendra hadapsar

tanaya.banodkar@gmail.com8087602868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026